Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Focal Dystonia: early-phase trial registry

1 of 9 indexed Focal Dystonia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 1 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Focal Dystonia: 9 US clinical trials tracked, 1 recruiting.

Focal Dystonia is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Neurological Disorders and Stroke (NINDS), running 7 of these trials.

Enrollment posture brief

Registry condition focal-dystonia

OPEN 1 | RECR 11% | LATE 0 | EARLY 4 | RANK #1916 | SPON 7

Nearest open-share peer: Alcohol Use Disorders (11% recruiting · 9 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%Focal Dystonia (this)11%
Open-enrollment share among volume-matched conditions near Focal Dystonia

Focal Dystonia lists 1 open slots (11% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Focal Dystonia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Focal Dystonia is recruiting below its size-band peers.

    1 of 9 indexed trials (11.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Focal Dystonia research.

    National Institute of Neurological Disorders and Stroke (NINDS) accounts for 7 of 9 trials (77.8%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Focal Dystonia trials plan to enrol fewer than 100 people.

    Median target enrolment is 24 among the 9 trials that report a genuine target (sentinel values excluded). 9 of those (100%) plan for fewer than 100 participants.

  4. Focal Dystonia splits between interventional and observational designs.

    6 interventional and 3 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 22

Open and recent trials

9 total, page 1 of 1

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Named interventions

Most-linked intervention names on Focal Dystonia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Amlodipine plus Botulinum toxin Drug
1 trials
Acetyl-Hexapeptide Topical Treatment Drug
1 trials
[18F]FP-TZTP Drug
1 trials
repetitive transcranial magnetic stimulation (rTMS) Procedure
1 trials
Medtronic Activa Rechargeable System Device
1 trials
DBS surgery Procedure
1 trials
Electrical stimulation Device
1 trials
repetitive transcranial magnetic stimulation (rTMS) Device
1 trials

US sites by state

Facility locations filed on Focal Dystonia trials. A trial with sites in several states counts in each.

Maryland 8 trials
New York 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Focal Dystonia page

9 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Focal Dystonia condition card totals 9 registered trials; most-linked intervention Amlodipine plus Botulinum toxin; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.